151 related articles for article (PubMed ID: 2998653)
1. Linkage relationships of paraoxonase (PON) with other markers: indication of PON-cystic fibrosis synteny.
Eiberg H; Mohr J; Schmiegelow K; Nielsen LS; Williamson R
Clin Genet; 1985 Oct; 28(4):265-71. PubMed ID: 2998653
[TBL] [Abstract][Full Text] [Related]
2. Linkage between the loci for cystic fibrosis and paraoxonase.
Schmiegelow K; Eiberg H; Tsui LC; Buchwald M; Phelan PD; Williamson R; Warwick W; Niebuhr E; Mohr J; Schwartz M
Clin Genet; 1986 May; 29(5):374-7. PubMed ID: 3017612
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker.
Tsui LC; Buchwald M; Barker D; Braman JC; Knowlton R; Schumm JW; Eiberg H; Mohr J; Kennedy D; Plavsic N
Science; 1985 Nov; 230(4729):1054-7. PubMed ID: 2997931
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of the human serum paraoxonase activity polymorphism.
Humbert R; Adler DA; Disteche CM; Hassett C; Omiecinski CJ; Furlong CE
Nat Genet; 1993 Jan; 3(1):73-6. PubMed ID: 8098250
[TBL] [Abstract][Full Text] [Related]
5. A linkage study of cystic fibrosis in extended multigenerational pedigrees.
Watkins PC; Schwartz R; Hoffman N; Stanislovitis P; Doherty R; Klinger K
Am J Hum Genet; 1986 Dec; 39(6):735-43. PubMed ID: 2879440
[TBL] [Abstract][Full Text] [Related]
6. Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins.
Saha N; Roy AC; Teo SH; Tay JS; Ratnam SS
Clin Genet; 1991 Oct; 40(4):277-82. PubMed ID: 1661643
[TBL] [Abstract][Full Text] [Related]
7. Linkage of cystic fibrosis locus and polymorphic DNA markers in 14 families.
Naylor SL; Barnett DR; Buchanan JM; Latimer J; Wieder K; Marshall S; Gardner J; Denning CR; Gluckson M; Pinero R
Am J Hum Genet; 1986 Dec; 39(6):707-12. PubMed ID: 3026173
[TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase polymorphism in three populations of southeast Asia.
Roy AC; Saha N; Tay JS; Ratnam SS
Hum Hered; 1991; 41(4):265-9. PubMed ID: 1664414
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes.
Adkins S; Gan KN; Mody M; La Du BN
Am J Hum Genet; 1993 Mar; 52(3):598-608. PubMed ID: 7916578
[TBL] [Abstract][Full Text] [Related]
10. Linkage of cystic fibrosis to the pro alpha 2(I) collagen gene, COL1A2, on chromosome 7.
Buchwald M; Zsiga M; Markiewicz D; Plavsic N; Kennedy D; Zengerling S; Willard HF; Tsipouras P; Schmiegelow K; Schwartz M
Cytogenet Cell Genet; 1986; 41(4):234-9. PubMed ID: 3011363
[TBL] [Abstract][Full Text] [Related]
11. An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism.
La Du BN; Piko JI; Eckerson HW; Vincent-Viry M; Siest G
Ann Biol Clin (Paris); 1986; 44(4):369-72. PubMed ID: 3024532
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of cystic fibrosis: linkage of DNA and classical markers in multiplex families.
Bowcock AM; Crandall J; Daneshvar L; Lee GM; Young B; Zunzunegui V; Craik C; Cavalli-Sforza LL; King MC
Am J Hum Genet; 1986 Dec; 39(6):699-706. PubMed ID: 3026172
[TBL] [Abstract][Full Text] [Related]
13. Serum paraoxonase/arylesterase activity affects outcome in ischemic stroke patients.
Michalak S; Kazmierski R; Hellmann A; Wysocka E; Kocialkowska-Adamczewska D; Wencel-Warot A; Nowinski WL
Cerebrovasc Dis; 2011; 32(2):124-32. PubMed ID: 21778709
[TBL] [Abstract][Full Text] [Related]
14. Possible heterogeneity in the phosphoglycolate phosphatase (PGP)-haptoglobin alpha (HPA) linkage.
Bale SJ; Chakravarti A; Ferrell RE; Spence MA
Am J Hum Genet; 1984 Jul; 36(4):808-14. PubMed ID: 6089552
[TBL] [Abstract][Full Text] [Related]
15. Localization of cystic fibrosis locus to human chromosome 7cen-q22.
Wainwright BJ; Scambler PJ; Schmidtke J; Watson EA; Law HY; Farrall M; Cooke HJ; Eiberg H; Williamson R
Nature; 1985 Nov 28-Dec 4; 318(6044):384-5. PubMed ID: 2999612
[TBL] [Abstract][Full Text] [Related]
16. Genetic homogeneity of cystic fibrosis.
Klinger K; Stanislovitis P; Hoffman N; Watkins PC; Schwartz R; Doherty R; Scambler P; Farrall M; Williamson R; Wainwright B
Nucleic Acids Res; 1986 Nov; 14(21):8681-6. PubMed ID: 3786136
[TBL] [Abstract][Full Text] [Related]
17. Association between PON 1 polymorphisms, PON activity and diabetes complications.
Hofer SE; Bennetts B; Chan AK; Holloway B; Karschimkus C; Jenkins AJ; Silink M; Donaghue KC
J Diabetes Complications; 2006; 20(5):322-8. PubMed ID: 16949520
[TBL] [Abstract][Full Text] [Related]
18. The polymorphic paraoxonase/arylesterase isozymes of human serum.
La Du BN; Eckerson HW
Fed Proc; 1984 May; 43(8):2338-41. PubMed ID: 6325253
[TBL] [Abstract][Full Text] [Related]
19. Genetics and linkage relationships of the C3 polymorphism: discovery of C3-Se linkage and assignment of LES-C3-DM-Se-PEPD-Lu synteny to chromosome 19.
Eiberg H; Mohr J; Nielsen LS; Simonsen N
Clin Genet; 1983 Sep; 24(3):159-70. PubMed ID: 6627719
[TBL] [Abstract][Full Text] [Related]
20. Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases.
Castellazzi M; Trentini A; Romani A; Valacchi G; Bellini T; Bonaccorsi G; Fainardi E; Cavicchio C; Passaro A; Zuliani G; Cervellati C
Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):356-363. PubMed ID: 27312742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
